Search

Author/Creator Protheroe, Andrew

1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022)

Authors:
Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;...
Journal:
Lancet
Issue:
Volume 399:Issue 10323(2022)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Issue 5 (May 2019)

Authors:
Fizazi, Karim; Tran, NamPhuong; Fein, Luis; Matsubara, Nobuaki; Rodriguez-Antolin, Alfredo; Alekseev, Boris Y; Özgüroğlu, Mustafa; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew; Sulur, Giri; Luna, Yesenia; Li, Susan; Mundle, Suneel; Chi, Kim N
Journal:
Lancet oncology
Issue:
Volume 20:Issue 5(2019)
Page Start:
686
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Issue 10024 (19th March 2016)

Authors:
James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman,...
Journal:
Lancet
Issue:
Volume 387:Issue 10024(2016)
Page Start:
1163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study. (November 2022)

Authors:
Lee, Lennard Y.W.; Ionescu, Maria C.; Starkey, Thomas; Little, Martin; Tilby, Michael; Tripathy, Arvind R.; Mckenzie, Hayley S.; Al-Hajji, Youssra; Appanna, Nathan; Barnard, Matthew; Benny, Liza; Burnett, Alexander; Cattell, Emma L.; Clark, James J.; Khan, Sam; Ghafoor, Qamar; Panneerselvam, Hari...
Journal:
European journal of cancer
Issue:
Volume 175(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK. Issue 9 (30th October 2018)

Authors:
Watson, Robert; Peña, Hugo; Tsakok, Maria; Joseph, Johnson; Stoneham, Sara; Shamash, Jonathan; Joffe, Johnathan; Mazhar, Danish; Traill, Zoe; Ho, Ling-Pei; Brand, Sue; Protheroe, Andrew
Journal:
British journal of cancer
Issue:
Volume 119:Issue 9(2018)
Page Start:
1044
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Issue 3 (March 2016)

Authors:
Armstrong, Andrew J; Halabi, Susan; Eisen, Tim; Broderick, Samuel; Stadler, Walter M; Jones, Robert J; Garcia, Jorge A; Vaishampayan, Ulka N; Picus, Joel; Hawkins, Robert E; Hainsworth, John D; Kollmannsberger, Christian K; Logan, Theodore F; Puzanov, Igor; Pickering, Lisa M; Ryan, Christopher W;...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 3(2016:Mar.)
Page Start:
378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). Issue 22 (1st August 2022)

Authors:
Joffe, Johnathan K.; Cafferty, Fay H.; Murphy, Laura; Rustin, Gordon J.S.; Sohaib, Syed A.; Gabe, Rhian; Stenning, Sally P.; James, Elizabeth; Noor, Dipa; Wade, Simona; Schiavone, Francesca; Swift, Sarah; Dunwoodie, Elaine; Hall, Marcia; Sharma, Anand; Braybrooke, Jeremy; Shamash, Jonathan; Logue...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 22(2022)
Page Start:
2468
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗